Sign in

Oric Pharmaceuticals, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.14 0.14 0.11 0.09 0.08 0.07 0.03 0.02 0.02
Operating income -0.14 -0.14 -0.11 -0.09 -0.08 -0.07 -0.03 -0.02 -0.02
Non-operating income (net) 0.01 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.13 -0.13 -0.10 -0.09 -0.08 -0.07 -0.03 -0.02 -0.02
Income tax expense 0.00 0.00 0.02 0.00 0.00
Net income -0.13 -0.13 -0.10 -0.09 -0.08 -0.07 -0.03 -0.02 -0.02
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.04 0.03 0.04 0.04 0.03 0.04 0.04 0.04 0.03 0.03 0.03 0.02 0.03 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01
Operating income -0.04 -0.03 -0.04 -0.04 -0.03 -0.04 -0.04 -0.04 -0.03 -0.03 -0.03 -0.02 -0.03 -0.02 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.03 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.04 -0.03 -0.03 -0.04 -0.03 -0.04 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.03 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.04 -0.03 -0.03 -0.04 -0.03 -0.04 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.03 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total cash and short-term investments + 0.28 0.26 0.21 0.21 0.24 0.29 0.09 0.04 0.03
Other current assets 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.29 0.26 0.21 0.21 0.24 0.30 0.09 0.04 0.03
Total non-current assets + 0.12 0.01 0.04 0.04 0.06 0.00 0.00 0.00 0.00
Total assets 0.41 0.27 0.25 0.25 0.30 0.30 0.09 0.05 0.03
Total current liabilities + 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.00 0.00
Total non-current liabilities + 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.11 0.00
Total liabilities 0.03 0.03 0.03 0.03 0.03 0.01 0.01 0.11 0.00
Total stockholders' equity + 0.38 0.24 0.22 0.22 0.27 0.29 0.09 -0.06 0.03
Common shares outstanding 88 70 51 40 38 22 30 2 1
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Total cash and short-term investments + 0.28 0.28 0.29 0.28 0.20 0.26 0.27 0.29 0.32 0.21 0.23 0.26 0.19 0.21 0.19 0.23 0.23 0.24 0.29 0.26 0.28 0.29 0.19 0.20 0.08 0.09 0.00 0.00 0.04
Other current assets 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.29 0.29 0.30 0.29 0.21 0.26 0.28 0.29 0.32 0.21 0.23 0.27 0.19 0.21 0.20 0.23 0.24 0.24 0.29 0.26 0.28 0.30 0.19 0.20 0.08 0.09 0.04
Total non-current assets + 0.15 0.12 0.14 0.06 0.03 0.01 0.02 0.03 0.03 0.04 0.04 0.02 0.03 0.04 0.04 0.03 0.04 0.06 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.04
Total assets 0.44 0.41 0.43 0.35 0.24 0.27 0.30 0.33 0.35 0.25 0.27 0.29 0.23 0.25 0.24 0.26 0.28 0.30 0.31 0.27 0.28 0.30 0.19 0.20 0.09 0.09
Total current liabilities + 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01
Total non-current liabilities + 0.00 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.18 0.00
Total liabilities 0.02 0.03 0.02 0.02 0.02 0.03 0.03 0.03 0.02 0.03 0.03 0.02 0.02 0.03 0.02 0.02 0.02 0.03 0.02 0.01 0.01 0.01 0.01 0.01 0.18 0.01
Total stockholders' equity + 0.42 0.38 0.41 0.32 0.22 0.24 0.27 0.30 0.33 0.22 0.25 0.27 0.20 0.22 0.21 0.24 0.25 0.27 0.29 0.26 0.28 0.29 0.18 0.20 -0.10 0.09 0.04
Common shares outstanding 105 88 99 78 71 71 71 70 67 57 57 46 45 40 40 39 39 39 39 37 37 34 30 22 28 23 19 19 19
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Operating cash flow + -0.11 -0.11 -0.09 -0.08 -0.06 -0.05 -0.02 -0.02 -0.02
Cash flow from investing + -0.15 0.02 -0.04 -0.11 0.16 -0.22 0.00 0.00 0.00
Cash flow from financing + 0.25 0.13 0.09 0.03 0.05 0.25 0.07 0.04 0.00
Change in cash -0.01 0.04 -0.04 -0.16 0.15 -0.01 0.05 0.02 -0.02
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Operating cash flow + -0.03 -0.02 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
Cash flow from investing + -0.02 0.02 -0.11 -0.08 0.02 0.04 0.02 0.02 -0.06 0.02 -0.06 -0.02 0.01 0.03 0.00 -0.05 -0.09 0.00 0.04 0.08 0.04 -0.09 -0.12 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.06 0.00 0.11 0.13 0.00 0.00 0.00 0.00 0.13 0.00 0.00 0.09 0.09 0.02 0.00 0.00 0.00 0.00 0.05 0.00 0.00 0.13 0.00 0.13 0.00 0.00 0.01 0.05 0.02
Change in cash 0.01 0.00 -0.03 0.03 -0.01 0.02 -0.01 -0.01 0.03 0.00 -0.08 0.04 0.08 0.04 -0.02 -0.06 -0.11 -0.02 0.07 0.07 0.03 0.02 -0.13 0.12 -0.01 -0.01 0.00 0.04 0.01
4 days ago

Oric Pharmaceuticals, Inc. (ORIC) - Operating Expenses

1Y 2Y 5Y Max
9 days ago

Oric Pharmaceuticals, Inc. (ORIC) - Research And Development

1Y 2Y 5Y Max
9 days ago

Oric Pharmaceuticals, Inc. (ORIC) - Selling General And Administrative

1Y 2Y 5Y Max
9 days ago

Oric Pharmaceuticals, Inc. (ORIC) - Operating Income

1Y 2Y 5Y Max
9 days ago

Oric Pharmaceuticals, Inc. (ORIC) - Costof Goods And Services Sold

1Y 2Y 5Y Max
9 days ago

Oric Pharmaceuticals, Inc. (ORIC) - Cost Of Revenue

1Y 2Y 5Y Max
9 days ago

Oric Pharmaceuticals, Inc. (ORIC) - Total Revenue

1Y 2Y 5Y Max
9 days ago

Oric Pharmaceuticals, Inc. (ORIC) - Gross Profit

1Y 2Y 5Y Max
9 days ago

Oric Pharmaceuticals, Inc. (ORIC) - Property Plant Equipment

1Y 2Y 5Y Max
9 days ago

Oric Pharmaceuticals, Inc. (ORIC) - Short Long Term Debt Total

1Y 2Y 5Y Max
9 days ago